Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 USD | -0.76% | -5.76% | -12.67% |
Business Summary
Number of employees: 13
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Small Molecule Therapeutics
100.0
%
| 0 | nan % | 1 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 1 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yuichi Iwaki
FOU | Founder | 74 | 26/00/26 |
Jason Kruger
DFI | Director of Finance/CFO | 47 | 16/22/16 |
Kazuko Matsuda
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/10/01 |
David Crean
PRN | Corporate Officer/Principal | 59 | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hideki Nagao
BRD | Director/Board Member | 67 | 01/04/01 |
Yuichi Iwaki
FOU | Founder | 74 | 26/00/26 |
Carolyn Beaver
BRD | Director/Board Member | 66 | 20/20/20 |
Kazuko Matsuda
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/10/01 |
Nicole Lemerond
BRD | Director/Board Member | 49 | 04/23/04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 49,046,246 | 47,790,540 ( 97.44 %) | 0 | 97.44 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.67% | 64.25M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- MNOV Stock
- Company MediciNova, Inc.